Proficio Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,633
| Closed | -$453K | – | 451 |
|
|
2025
Q1 | $453K | Hold |
3,633
| – | – | 0.04% | 227 |
|
|
2024
Q4 | $480K | Buy |
+3,633
| New | +$511K | 0.04% | 200 |
|
|
2023
Q4 | – | Sell |
-1,798
| Closed | -$220K | – | 314 |
|
|
2023
Q3 | $220K | Sell |
1,798
-21,226
| -92% | -$2.7M | 0.03% | 269 |
|
|
2023
Q2 | $2.92M | Buy |
23,024
+1,440
| +7% | +$187K | 0.4% | 44 |
|
|
2023
Q1 | $2.79M | Buy |
21,584
+5,520
| +34% | +$723K | 0.44% | 39 |
|
|
2022
Q4 | $2.11M | Buy |
16,064
+150
| +0.9% | +$19.4K | 0.4% | 43 |
|
|
2022
Q3 | $1.86M | Buy |
15,914
+9,614
| +153% | +$1.19M | 0.34% | 48 |
|
|
2022
Q2 | $741K | Hold |
6,300
| – | – | 0.14% | 92 |
|
|
2022
Q1 | $821K | Hold |
6,300
| – | – | 0.12% | 89 |
|
|
2021
Q4 | $962K | Hold |
6,300
| – | – | 0.13% | 97 |
|
|
2021
Q3 | $1.02M | Hold |
6,300
| – | – | 0.13% | 94 |
|
|
2021
Q2 | $1.03M | Hold |
6,300
| – | – | 0.13% | 94 |
|
|
2021
Q1 | $949K | Hold |
6,300
| – | – | 0.12% | 92 |
|
|
2020
Q4 | $954K | Hold |
6,300
| – | – | 0.15% | 74 |
|
|
2020
Q3 | $853K | Hold |
6,300
| – | – | 0.15% | 73 |
|
|
2020
Q2 | $861K | Hold |
6,300
| – | – | 0.18% | 64 |
|
|
2020
Q1 | $795K | Hold |
6,300
| – | – | 0.2% | 68 |
|
|
2019
Q4 | $759K | Hold |
6,300
| – | – | 0.22% | 66 |
|
|
2019
Q3 | $627K | Sell |
6,300
-1,200
| -16% | -$126K | 0.23% | 62 |
|
|
2019
Q2 | $818K | Hold |
7,500
| – | – | 0.28% | 58 |
|
|
2019
Q1 | $838K | Sell |
7,500
-285
| -4% | -$31.3K | 0.3% | 57 |
|
|
2018
Q4 | $751K | Hold |
7,785
| – | – | 0.33% | 59 |
|
|
2018
Q3 | $949K | Hold |
7,785
| – | – | 0.31% | 56 |
|
|
2018
Q2 | $855K | Buy |
7,785
+285
| +4% | +$30.5K | 0.35% | 57 |
|
|
2018
Q1 | $801K | Sell |
7,500
-1,800
| -19% | -$200K | 0.24% | 72 |
|
|
2017
Q4 | $993K | Sell |
9,300
-600
| -6% | -$64.1K | 0.32% | 57 |
|
|
2017
Q3 | $1.1M | Hold |
9,900
| – | – | 0.45% | 49 |
|
|
2017
Q2 | $1.05M | Hold |
9,900
| – | – | 0.43% | 54 |
|
|
2017
Q1 | $961K | Buy |
9,900
+8,100
| +450% | +$775K | 0.42% | 60 |
|
|
2016
Q4 | $159K | Hold |
1,800
| – | – | 0.07% | 148 |
|
|
2016
Q3 | $174K | Hold |
1,800
| – | – | 0.1% | 137 |
|
|
2016
Q2 | $173K | Buy |
1,800
+900
| +100% | +$80.8K | 0.11% | 138 |
|
|
2016
Q1 | $78K | Buy |
+900
| New | +$80.5K | 0.07% | 152 |
|
Other funds holding IBB
CB
Proficio Capital Partners's IBB Position: Q2 2025 in Review
Proficio Capital Partners sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 3,633 shares — an estimated $453K sold.
Proficio Capital Partners first reported a position in IBB in Q1 2016 and held it in 33 quarters. The position peaked at $2.92M in Q2 2023. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.
- Proficio Capital Partners reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
- Proficio Capital Partners sold 3,633 iShares Biotechnology ETF shares in Q2 2025, an estimated $453K.
- Proficio Capital Partners first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 33 quarters.
- Proficio Capital Partners's iShares Biotechnology ETF position peaked at $2.92M in Q2 2023.
- 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.
Based on Proficio Capital Partners's 13F filing for Q2 2025, filed 7 Aug 2025.